Temozolomide for aggressive ACTH pituitary tumors: failure of a second course of treatment

M Campderá, N Palacios, J Aller, R Magallón, P Martín… - Pituitary, 2016 - Springer
Introduction Temozolomide (TMZ) is an oral alkylating agent that has been used over the
past 8 years to treat aggressive pituitary tumors resistant to conventional therapy. To date …

Temozolomide for aggressive ACTH pituitary tumors: failure of a second course of treatment.

M Campderá, N Palacios, J Aller, R Magallón, P Martín… - Pituitary, 2016 - europepmc.org
Materials and methods We present a retrospective review of the medical records of three
patients with aggressive ACTH producing adenomas treated with TMZ. In the three cases …

Temozolomide for aggressive ACTH pituitary tumors: failure of a second course of treatment

M Campderá, N Palacios, J Aller, R Magallón… - …, 2016 - pubmed.ncbi.nlm.nih.gov
Introduction Temozolomide (TMZ) is an oral alkylating agent that has been used over the
past 8 years to treat aggressive pituitary tumors resistant to conventional therapy. To date …

Temozolomide for aggressive ACTH pituitary tumors: failure of a second course of treatment

M Campderá, N Palacios, J Aller, R Magallón, P Martín… - Pituitary, 2016 - infona.pl
Introduction Temozolomide (TMZ) is an oral alkylating agent that has been used over the
past 8 years to treat aggressive pituitary tumors resistant to conventional therapy. To date …

[引用][C] Temozolomide for aggressive ACTH pituitary tumors: failure of a second course of treatment

M Campderá, N Palacios, J Aller, R Magallón, P Martín… - Pituitary, 2015 - cir.nii.ac.jp

Temozolomide for aggressive ACTH pituitary tumors: failure of a second course of treatment

M Campderá, N Palacios, J Aller, R Magallón… - Pituitary, 2016 - search.proquest.com
Materials and Methods We present a retrospective review of the medical records of three
patients with aggressive ACTH producing adenomas treated with TMZ. In the three cases …

[引用][C] Temozolomide for aggressive ACTH pituitary tumors: failure of a second course of treatment

M Campderá, N Palacios, J Aller, R Magallón, P Martín… - Pituitary, 2016 - Springer